

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001722"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001722" />

    <meta name="citation_title" content="Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target"/>
    <meta itemprop="name" content="Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target"/>

      <meta name="citation_author" content="Mariëlle I. Gallegos Ruiz"/>
            <meta name="citation_author_institution" content="Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Karijn Floor"/>
            <meta name="citation_author_institution" content="Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Paul Roepman"/>
            <meta name="citation_author_institution" content="Agendia BV, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="José A. Rodriguez"/>
            <meta name="citation_author_institution" content="Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Gerrit A. Meijer"/>
            <meta name="citation_author_institution" content="Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Wolter J. Mooi"/>
            <meta name="citation_author_institution" content="Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Ewa Jassem"/>
            <meta name="citation_author_institution" content="University of Gdansk, Gdansk, Poland"/>
      <meta name="citation_author" content="Jacek Niklinski"/>
            <meta name="citation_author_institution" content="University of Bialystok, Bialystok, Poland"/>
      <meta name="citation_author" content="Thomas Muley"/>
            <meta name="citation_author_institution" content="Thoraxklinik Heidelberg, University of Heidelberg, Heidelberg, Germany"/>
      <meta name="citation_author" content="Nico van Zandwijk"/>
            <meta name="citation_author_institution" content="Netherlands Cancer Institute, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Egbert F. Smit"/>
            <meta name="citation_author_institution" content="Department of Pulmonary Diseases, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Kristin Beebe"/>
            <meta name="citation_author_institution" content="Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America"/>
      <meta name="citation_author" content="Len Neckers"/>
            <meta name="citation_author_institution" content="Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America"/>
      <meta name="citation_author" content="Bauke Ylstra"/>
            <meta name="citation_author_institution" content="Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>
      <meta name="citation_author" content="Giuseppe Giaccone"/>
            <meta name="citation_author_institution" content="Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands"/>

    <meta name="citation_date" content="2008/3/5"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001722.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e0001722"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Cancer statistics, 2006.; citation_author=A Jemal; citation_author=R Siegel; citation_author=E Ward; citation_author=T Murray; citation_author=JQ Xu; citation_journal_title=Ca-A Cancer Journal for Clinicians; citation_volume=56; citation_number=1; citation_pages=106-130; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Molecular genetics of lung cancer.; citation_author=Y Sekido; citation_author=KM Fong; citation_author=JD Minna; citation_journal_title=Annual Review of Medicine-Selected Topics in the Clinical Sciences; citation_volume=54; citation_number=2; citation_pages=73-87; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Chromosomal imbalances in human lung cancer.; citation_author=BR Balsara; citation_author=JR Testa; citation_journal_title=Oncogene; citation_volume=21; citation_number=3; citation_pages=6877-6883; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.; citation_author=K Chin; citation_author=S DeVries; citation_author=J Fridlyand; citation_author=PT Spellman; citation_author=R Roydasgupta; citation_journal_title=Cancer Cell; citation_volume=10; citation_number=4; citation_pages=529-541; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=CGHcall: calling aberrations for array CGH tumor profiles.; citation_author=MA van de Wiel; citation_author=KI Kim; citation_author=SJ Vosse; citation_author=WN van Wieringen; citation_author=SM Wilting; citation_journal_title=Bioinformatics; citation_volume=23; citation_number=5; citation_pages=892-894; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data.; citation_author=WN van Wieringen; citation_author=JAM Belien; citation_author=SJ Vosse; citation_author=EM Achame; citation_journal_title=Bioinformatics; citation_volume=22; citation_number=6; citation_pages=1919-1920; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Oncogenic pathway signatures in human cancers as a guide to targeted therapies.; citation_author=AH Bild; citation_author=G Yao; citation_author=JT Chang; citation_author=Q Wang; citation_author=A Potti; citation_journal_title=Nature; citation_volume=439; citation_number=7; citation_pages=353-357; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.; citation_author=Y Lu; citation_author=W Lemon; citation_author=PY Liu; citation_author=YJ Yi; citation_author=C Morrison; citation_journal_title=Plos Medicine; citation_volume=3; citation_number=8; citation_pages=2229-2243; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Human and mouse oligonucleotide-based array CGH.; citation_author=P van den IJssel; citation_author=M Tijssen; citation_author=SF Chin; citation_author=P Eijk; citation_author=B Carvalho; citation_journal_title=Nucleic Acids Research; citation_volume=33; citation_number=9; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Converting a breast cancer microarray signature into a high-throughput diagnostic test.; citation_author=AM Glas; citation_author=A Floore; citation_author=LJMJ Delahaye; citation_author=AT Witteveen; citation_author=RCF Pover; citation_journal_title=Bmc Genomics; citation_volume=7; citation_number=10; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=CGHcall: calling aberrations for array CGH tumor profiles.; citation_author=MA van de Wiel; citation_author=KI Kim; citation_author=SJ Vosse; citation_author=WN van Wieringen; citation_author=SM Wilting; citation_journal_title=Bioinformatics; citation_volume=23; citation_number=11; citation_pages=892-894; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Controlling the False Discovery Rate-A Practical and Powerful Approach to Multiple Testing.; citation_author=Y Benjamini; citation_author=Y Hochberg; citation_journal_title=Journal of the Royal Statistical Society Series B-Methodological; citation_volume=57; citation_number=12; citation_pages=289-300; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.; citation_author=JP Schouten; citation_author=CJ McElgunn; citation_author=R Waaijer; citation_author=D Zwijnenburg; citation_author=F Diepvens; citation_journal_title=Nucleic Acids Research; citation_volume=30; citation_number=13; citation_pages=e57; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.; citation_author=TW Schulte; citation_author=LM Neckers; citation_journal_title=Cancer Chemotherapy and Pharmacology; citation_volume=42; citation_number=14; citation_pages=273-279; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features.; citation_author=T Shibata; citation_author=S Uryu; citation_author=A Kokubu; citation_author=F Hosoda; citation_author=M Ohki; citation_journal_title=Clinical Cancer Research; citation_volume=11; citation_number=15; citation_pages=6177-6185; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=High-resolution genomic profiles of human lung cancer.; citation_author=G Tonon; citation_author=KK Wong; citation_author=G Maulik; citation_author=C Brennan; citation_author=B Feng; citation_journal_title=Proceedings of the National Academy of Sciences of the United States of America; citation_volume=102; citation_number=16; citation_pages=9625-9630; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Gene-expression profiles predict survival of patients with lung adenocarcinoma.; citation_author=DG Beer; citation_author=SLR Kardia; citation_author=CC Huang; citation_author=TJ Giordano; citation_author=AM Levin; citation_journal_title=Nature Medicine; citation_volume=8; citation_number=17; citation_pages=816-824; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.; citation_author=DA Wigle; citation_author=I Jurisica; citation_author=N Radulovich; citation_author=M Pintilie; citation_author=J Rossant; citation_journal_title=Cancer Research; citation_volume=62; citation_number=18; citation_pages=3005-3008; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A five-gene signature and clinical outcome in non-small-cell lung cancer.; citation_author=HY Chen; citation_author=SL Yu; citation_author=CH Chen; citation_author=GC Chang; citation_author=CY Chen; citation_journal_title=New England Journal of Medicine; citation_volume=356; citation_number=19; citation_pages=11-20; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.; citation_author=TJ Lynch; citation_author=DW Bell; citation_author=R Sordella; citation_author=S Gurubhagavatula; citation_author=RA Okimoto; citation_journal_title=New England Journal of Medicine; citation_volume=350; citation_number=20; citation_pages=2129-2139; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.; citation_author=W Pao; citation_author=TY Wang; citation_author=GJ Riely; citation_author=VA Miller; citation_author=QL Pan; citation_journal_title=Plos Medicine; citation_volume=2; citation_number=21; citation_pages=57-61; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials.; citation_author=D Slamon; citation_author=M Pegram; citation_journal_title=Seminars in Oncology; citation_volume=28; citation_number=22; citation_pages=13-19; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.; citation_author=BR Balsara; citation_author=G Sonoda; citation_author=S duManoir; citation_author=JM Siegfried; citation_author=E Gabrielson; citation_journal_title=Cancer Research; citation_volume=57; citation_number=23; citation_pages=2116-2120; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.; citation_author=JR Pollack; citation_author=T Sorlie; citation_author=CM Perou; citation_author=CA Rees; citation_author=SS Jeffrey; citation_journal_title=Proceedings of the National Academy of Sciences of the United States of America; citation_volume=99; citation_number=24; citation_pages=12963-12968; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.; citation_author=R Redon; citation_author=D Muller; citation_author=K Caulee; citation_author=K Wanherdrick; citation_author=J Abecassis; citation_journal_title=Cancer Research; citation_volume=61; citation_number=25; citation_pages=4122-4129; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes.; citation_author=ST Tay; citation_author=SH Leong; citation_author=K Yu; citation_author=A Aggarwal; citation_author=SY Tan; citation_journal_title=Cancer Research; citation_volume=63; citation_number=26; citation_pages=3309-3316; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas.; citation_author=JS Choi; citation_author=LT Zheng; citation_author=E Ha; citation_author=YJ Lim; citation_author=YH Kim; citation_journal_title=Lung; citation_volume=184; citation_number=27; citation_pages=355-362; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Hsp90 activation and cell cycle regulation.; citation_author=F Burrows; citation_author=H Zhang; citation_author=A Kamal; citation_journal_title=Cell Cycle; citation_volume=3; citation_number=28; citation_pages=1530-1536; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.; citation_author=SC Yang; citation_author=S Qu; citation_author=M Perez-Tores; citation_author=A Sawai; citation_author=N Rosen; citation_journal_title=Cancer Research; citation_volume=66; citation_number=29; citation_pages=6990-6997; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins.; citation_author=T Shimamura; citation_author=AM Lowell; citation_author=JA Engelman; citation_author=GI Shapiro; citation_journal_title=Cancer Research; citation_volume=65; citation_number=30; citation_pages=6401-6408; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Heat shock protein 90: A unique chemotherapeutic target.; citation_author=SB Cullman; citation_author=L Whitesell; citation_journal_title=Seminars in Oncology; citation_volume=33; citation_number=31; citation_pages=457-465; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Targeting multiple signal transduction pathways through inhibition of Hsp90.; citation_author=H Zhang; citation_author=F Burrows; citation_journal_title=Journal of Molecular Medicine-Jmm; citation_volume=82; citation_number=32; citation_pages=488-499; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Glioblastoma (GBM) cells that overexpress epidermal growth factor receptors (EGFR) are sensitive to HSP90 but not EGFR kinase inhibitors.; citation_author=CY Thomas; citation_author=M Stallings-Mann; citation_author=H Zang; citation_author=YC Yang; citation_author=F Burrows; citation_journal_title=Clinical Cancer Research; citation_volume=9; citation_number=33; citation_pages=6098S; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=17-allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels.; citation_author=M Braga-Basaria; citation_author=E Hardy; citation_author=R Gottfried; citation_author=KD Burman; citation_author=M Saji; citation_journal_title=Journal of Clinical Endocrinology and Metabolism; citation_volume=89; citation_number=34; citation_pages=2982-2988; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Disruption of the EF-2 kinase/Hsp90 protein complex: A possible mechanism to inhibit glioblastoma by geldanamycin.; citation_author=J Yang; citation_author=JM Yang; citation_author=M Iannone; citation_author=WJ Shih; citation_author=Y Lin; citation_journal_title=Cancer Research; citation_volume=61; citation_number=35; citation_pages=4010-4016; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1.; citation_author=B Zsebik; citation_author=A Citri; citation_author=J Isola; citation_author=Y Yarden; citation_author=J Szollosi; citation_journal_title=Immunology Letters; citation_volume=104; citation_number=36; citation_pages=146-155; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.; citation_author=WP Xu; citation_author=L Neckers; citation_journal_title=Clinical Cancer Research; citation_volume=13; citation_number=37; citation_pages=1625-1629; citation_date=2007; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target"/>
    <meta name="twitter:description" content="BackgroundLung cancer causes approximately 1.2 million deaths per year worldwide, and non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. Understanding the molecular events in non-small cell lung cancer (NSCLC) is essential to improve early diagnosis and treatment for this disease.Methodology and Principal FindingsIn an attempt to identify novel NSCLC related genes, we performed a genome-wide screening of chromosomal copy number changes affecting gene expression using microarray based comparative genomic hybridization and gene expression arrays on 32 radically resected tumor samples from stage I and II NSCLC patients. An integrative analysis tool was applied to determine whether chromosomal copy number affects gene expression. We identified a deletion on 14q32.2-33 as a common alteration in NSCLC (44%), which significantly influenced gene expression for HSP90, residing on 14q32. This deletion was correlated with better overall survival (P&#8202;=&#8202;0.008), survival was also longer in patients whose tumors had low expression levels of HSP90. We extended the analysis to three independent validation sets of NSCLC patients, and confirmed low HSP90 expression to be related with longer overall survival (P&#8202;=&#8202;0.003, P&#8202;=&#8202;0.07 and P&#8202;=&#8202;0.04). Furthermore, in vitro treatment with an HSP90 inhibitor had potent antiproliferative activity in NSCLC cell lines.ConclusionsWe suggest that targeting HSP90 will have clinical impact for NSCLC patients."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001722.g004"/>

  <meta property="og:title" content="Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=3128'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=2285'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=57&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001722">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001722" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001722&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Mariëlle I. Gallegos Ruiz, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Karijn Floor, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Paul Roepman, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Agendia BV, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            José A. Rodriguez, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Gerrit A. Meijer, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Wolter J. Mooi, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ewa Jassem, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  University of Gdansk, Gdansk, Poland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jacek Niklinski, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  University of Bialystok, Bialystok, Poland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Thomas Muley, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Thoraxklinik Heidelberg, University of Heidelberg, Heidelberg, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Nico van Zandwijk, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Netherlands Cancer Institute, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Egbert F. Smit, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Pulmonary Diseases, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Kristin Beebe, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Len Neckers, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Bauke Ylstra
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Bauke Ylstra, Giuseppe Giaccone</p>

              
              

                <p>Affiliation:
                  Department of Pathology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Giuseppe Giaccone
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Bauke Ylstra, Giuseppe Giaccone</p>

              
              <p>*E-mail: <a href="mailto:giacconeg@mail.nih.gov">giacconeg@mail.nih.gov</a></p>

                <p>Affiliation:
                  Department of Medical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 05, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001722</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001722-t001" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-g001" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-t002" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-g002" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-g003" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-t003" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001722-g004" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001722">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001722" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Lung cancer causes approximately 1.2 million deaths per year worldwide, and non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. Understanding the molecular events in non-small cell lung cancer (NSCLC) is essential to improve early diagnosis and treatment for this disease.</p>


<h3>Methodology and Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>In an attempt to identify novel NSCLC related genes, we performed a genome-wide screening of chromosomal copy number changes affecting gene expression using microarray based comparative genomic hybridization and gene expression arrays on 32 radically resected tumor samples from stage I and II NSCLC patients. An integrative analysis tool was applied to determine whether chromosomal copy number affects gene expression. We identified a deletion on 14q32.2-33 as a common alteration in NSCLC (44%), which significantly influenced gene expression for HSP90, residing on 14q32. This deletion was correlated with better overall survival (P = 0.008), survival was also longer in patients whose tumors had low expression levels of HSP90. We extended the analysis to three independent validation sets of NSCLC patients, and confirmed low HSP90 expression to be related with longer overall survival (P = 0.003, P = 0.07 and P = 0.04). Furthermore, in vitro treatment with an HSP90 inhibitor had potent antiproliferative activity in NSCLC cell lines.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>We suggest that targeting HSP90 will have clinical impact for NSCLC patients.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Gallegos Ruiz MI, Floor K, Roepman P, Rodriguez JA, Meijer GA, et al.  (2008) Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target. PLoS ONE 3(3):
          e0001722.
            doi:10.1371/journal.pone.0001722</p><p><strong>Academic Editor: </strong>Christoph Plass, Ohio State University, United States of America</p><p><strong>Received:</strong> December 28, 2007; <strong>Accepted:</strong> February 4, 2008; <strong>Published:</strong> March 5, 2008</p><p><strong>Copyright:</strong> © 2008 Gallegos Ruiz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>The authors have no support or funding to report.</p><p><strong>Competing interests:</strong> Paul Roepman is employed by Agendia B.V.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Lung cancer is the leading cause of cancer deaths worldwide <a href="#pone.0001722-Jemal1">[1]</a>, and non-small cell lung cancer (NSCLC) represents 85% of lung cancers. A better understanding of the molecular events underlying the development and progression of the disease may contribute to improve clinical management of NSCLC patients. A number of genes, e.g. P53, RAS, P16 and EGFR, have been shown to be altered in NSCLC <a href="#pone.0001722-Sekido1">[2]</a>. Given the heterogeneous and complex nature of this tumor type, it is likely that many genes driving NSCLC tumorigenesis have yet to be identified.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Chromosomal aberrations are thought to be critical events in human tumorigenesis, and several genomic regions frequently harboring DNA gains (3q, 5p, 7q, 8q, 11q and 16p) and losses (3p, 4q, 5q, 6q, 8p 9p and 13q, 17q) have been identified in NSCLC patients <a href="#pone.0001722-Balsara1">[3]</a>. Using array based comparative genomic hybridization (aCGH) and gene expression microarrays, DNA copy number changes and gene expression can be measured throughout the whole genome of tumor cells. By combining the data from these analyses, it is possible to obtain an integrated genome wide view of gene dosage aberrations and their effect on gene expression, which might help in identifying genes important in NSCLC <a href="#pone.0001722-Chin1">[4]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>In the present study, we have performed an integrative analysis of chromosomal copy number and gene expression on radically resected tumor samples from 32 NSCLC patients. Two new algorithms, ‘CGH call’<a href="#pone.0001722-vandeWiel1">[5]</a> and ‘ACE-it’<a href="#pone.0001722-vanWieringen1">[6]</a>, were applied to analyze the data. We identified a deletion on chromosome region 14q32.2-33 in 44% of NSCLC patients. This deletion was related with improved patient survival, and was associated with decreased expression of HSP90, a molecular chaperone for several oncoproteins that is being explored as a novel target in anticancer therapy. Low HSP90 expression was correlated with improved survival in the 32 NSCLC patients analyzed initially. Further analysis of three independent sets of NSCLC patients confirmed a significant association between patient survival and HSP90 expression. In addition, <em>in vitro</em> experiments show NSCLC cell lines to be extremely sensitive to the HSP90 inhibitor 17-AAG. Our data suggest and important role for HSP90 in NSCLC.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3>
<h4>Patients and samples</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>The test set consisted of radically resected tumor specimens of 32 early stage NSCLC patients. Three patients had a survival time of less than 30 days and were considered postoperative deaths. Therefore these three patients are not included in the survival analyses. Patients had a median follow up of 86 months (range 0.4-135.5). Verbal informed consent had been obtained from all patients and handling of samples was in accordance with protocols approved by the ethical board “subcommissie voor de ethiek van het mensgebonden onderzoek” from the VU University Medical Center in Amsterdam.</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>The first validation set consisted of 140 radically resected NSCLC patients from the European lung cancer consortium. Patients had a median follow up of 35 months. All patients included had had no prior malignancy, pathological tumor stage 1 or 2 (T1-2), node stage 0+1 (N0-1), no distant metastasis (M0) at time of operation, and no residual disease after resection (R0). None of these patients received (neo)adjuvant chemo- or radiotherapy. The second validation consisted of 111 early stage NSCLC patients from Bild et al. <a href="#pone.0001722-Bild1">[7]</a>. The third validation set consisted of the publicly available “datasets 1 and 2” from Lu et al. <a href="#pone.0001722-Lu1">[8]</a> and contained 54 early stage NSCLC patients. A full description of patient characteristics of all four patient sets is provided in <a href="#pone-0001722-t001">Table 1</a>.</p>
<div class="figure" id="pone-0001722-t001"><div class="img"><a name="pone-0001722-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Clinical characteristics of test and validation patient sets</span></strong></p><span>doi:10.1371/journal.pone.0001722.t001</span></div>

<h4>Isolation of genomic DNA and array Comparative Genomic Hybridization</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Cryo-sections of frozen tissue samples, flanking the sections used for RNA and DNA isolation, were verified by the study pathologist (WM) to contain at least 50% of tumor cells. Genomic DNA was extracted from each sample using Trizol following manufacturer instructions (Life Technologies, Breda, The Netherlands). DNA labeling and hybridization on CGH 30K oligonucleotide microarrays was performed as described by van den IJssel et al <a href="#pone.0001722-vandenIJssel1">[9]</a>.</p>


<h4>RNA isolation and gene expression micro arrays</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>RNA isolation and cDNA labeling followed standard protocols. Hybridization was performed on Agilent platform according to standard procedures described by the manufacturer and elsewhere <a href="#pone.0001722-Glas1">[10]</a>.</p>


<h4>Data analysis</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>For array CGH, spot analysis and quality control were performed using BlueFuse version 3.2 (BlueGenome, Cambridge, UK). Breakpoints, gains, losses and amplifications were detected using the algorithm CGH call. This algorithm converts raw log2ratios to absolute measures of “loss”, “normal”, “gain” or “amplification” by applying a segmentation algorithm combined with a probability mixture model <a href="#pone.0001722-vandeWiel2">[11]</a>. In order to statistically test whether gene expression was affected by gene dosage we applied an array CGH expression integration tool, ACE-it<a href="#pone.0001722-vanWieringen1">[6]</a>, in which the called array CGH and normalized log10 ratios for expression arrays were used as input data. ACE-it uses the one-sided Wilcoxon rank sum statistics to test which chromosomal copy number aberrations recurrently affect RNA expression. Calculated p-values are adjusted for multiple testing using the Benjamini Hochberg method <a href="#pone.0001722-Benjamini1">[12]</a>. ACE-it only tests genes that meet the criteria of contamination and balance, which are controlled through a threshold on the number of samples. Here the threshold was set at a fixed default setting of 9 samples, meaning that only those chromosomal positions were taken into account that had at least 9 samples in one CGH calling status and no more than 9 in the other status. The entire array CGH data set of the test series (n = 32) is available at the GEO database (<a href="http://www.ncbi.nlm.nih.gov/projects/geo">http://www.ncbi.nlm.nih.gov/projects/geo</a>, accession number GSE7878). The gene expression data of both the test set (n = 32) and validation set 1 (n = 140) for the 359 genes identified by ACE-it is available at the Array Express database (<a href="http://www.ebi.ac.uk/aerep/login">www.ebi.ac.uk/aerep/login</a>, accession number Array design: A-MEXP-749, Experiment data: E-TABM-270).</p>
<a id="article1.body1.sec2.sec4.p2" name="article1.body1.sec2.sec4.p2"></a><p>Gene expression data of validation set 2 was obtained using Affymetrix Hu133plus2 chips (GEO accession number GSE3141). The mean value of the MAS5 calculated signal intensities of four probesets detecting HSP90AA1 was used in our calculations.</p>
<a id="article1.body1.sec2.sec4.p3" name="article1.body1.sec2.sec4.p3"></a><p>The third validation set contained gene expression data from Affymetrix Hu95 and Hu133 chips (GEO accession number GSE6253). The Hu95 chip contained one probeset detecting HSP90AA1 and the Hu133 chip contained four probesets, of which the mean value of the RMA calculated signal intensities was used in our calculations.</p>


<h4>Statistics</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>An univariate cox regression analysis was performed to investigate relation of gene expression values with survival time. Survival curves were constructed using the Kaplan Meier method and differences in overall were evaluated using the log-rank test. In the test set, three patients with less than 30 days survival time were excluded from the survival analysis, as their death was considered surgical mortality. To determine the independent effects of HSP90 expression, histologic subtype, tumor stage, age and gender, a multivariate cox regression analysis was performed. A P value of less than 0.05 was considered statistically significant.</p>


<h4>Multiplex Ligation dependent Probe Amplification (MLPA)</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>For Multiplex Ligation dependent Probe Amplification (MLPA), the subtelomere probe set P070 (MRC Holland, Amsterdam, The Netherlands) containing a probe located within the band 14q32.33 (region 104874216 to 105070384) was used. MLPA was performed according to manufacturer's instructions using 100ng DNA as input. DNA isolated from blood of a pool of healthy donors was used as reference sample. Probe signals were normalized by dividing the peak area of chromosome 14q by the peak area of chromosome 14p. MLPA generated 14q/14p ratios are plotted against the mean normalized log2ratios of the oligos in area 104787271-105071522 from the array (total of 11 oligos). This region covers the region of the MLPA probe.</p>


<h4>Quantitative RT-PCR</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>In order to validate expression values obtained via gene expression arrays, we performed quantitative real-time PCR using Taqman® technology and the ABI PRISM 7500 Sequence Detection System instrument equipped with the SDS version 1.3.0 software (Applied Biosystems, Foster City, CA, USA). Forward and reverse primers and probes were designed and produced by Applied Biosystems for HSP90AA1 (Hs00743767_sH), and for the endogenous control gene GUSB (Hs00939626_mi). PCR was carried out in a 25-µl reaction volume that contained 50 ng of cDNA, 1× TaqMan Universal PCR Master Mix, and the primer and probe sets for HSP90AA1 and GUSB. Each sample was analyzed in duplicate, and the average threshold cycle (Ct) values of each sample for GUSB, were subtracted from the average Ct values for HSP90AA1. Taqman-generated ΔCt values were log transformed to expression values and plotted against the Δlog2ratios between GUSB and HSP90AA1 from the expression array.</p>


<h4>Cell growth inhibition studies</h4>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1"></a><p>Growth inhibition following <em>in vitro</em> exposure to the clinically used Hsp90 inhibitor 17-AAG (InvivoGen, San Diego, CA) was examined in 4 EGFR wild type NSCLC cell lines (H460, H157, H441 and A549, obtained from Drs. P. Dennis and F. Kaye, NCI, Bethesda, MD). Briefly, 10<sup>5</sup> cells were seeded in 6-well tissue culture plates (Sigma-Aldrich, St. Louis, MO), allowed to adhere, and then continuously exposed to various concentrations of 17-AAG (0, 10, 30, 100, 300, 1000 nM) for 24, 48, or 72 hours. At each time point, cells were detached from the wells, incubated with trypan blue, and viable (trypan blue-excluding) cell number was determined in triplicate using a hemacytometer. The mean cell number with standard error bars is shown at each time point. In addition, the IC<sub>50</sub> (drug concentration at which 50% growth inhibition is obtained) of 17-AAG at 72 hours was determined for each cell line.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Gene dosage-related gene expression changes in NSCLC</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>Chromosomal aberrations were abundant in the 32 NSCLC patients analyzed. In order to identify breakpoints of gains and losses we applied the algorithm CGH call <a href="#pone.0001722-vandeWiel2">[11]</a>. In <a href="#pone-0001722-t002">Table 2</a> the chromosomal regions in which gains or losses were present in at least 20% of patients are listed. The statistical tool ACE-it <a href="#pone.0001722-vanWieringen1">[6]</a> was used to determine whether gene copy number affected gene expression. A total of 359 transcripts turned out to be significantly affected by copy number. In <a href="#pone-0001722-g001">Figure 1</a> the areas of affected genes are indicated for 32 NSCLC patients, shown in green (gained regions) or red (lost regions).</p>
<div class="figure" id="pone-0001722-g001"><div class="img"><a name="pone-0001722-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Percentage of called gains and losses and their effect on gene expression in 32 NSCLC patients.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>Summary plot for called gains and losses in 32 resected NSCLC patients with DNA copy number changes indicated in grey. Positive values indicate the percentage of samples found with a gain. Negative values indicate the percentage of samples harboring a loss at the specified chromosome location. Genes in specified regions affected by copy number gain are indicated in green and genes affected by copy number loss are indicated in red. A selection of affected genes is indicated. The full list of 359 affected transcripts can be found in supplementary <a href="#pone.0001722.s001">table S1</a>.</p>
<span>doi:10.1371/journal.pone.0001722.g001</span></div><div class="figure" id="pone-0001722-t002"><div class="img"><a name="pone-0001722-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Chromosomal regions with gains and losses present in &gt;20% of NSCLC patients analyzed</span></strong></p><span>doi:10.1371/journal.pone.0001722.t002</span></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>An univariate cox regression survival analysis was performed for expression of all 359 genes that were identified to be influenced by copy number (see supplementary <a href="#pone.0001722.s001">table S1</a>). After multiple testing correction (using the Benjamini Hochberg method) none of 359 genes remained significant for survival on this small patient set (n = 32). The top list of genes correlated with survival (ranked on raw p-values) contained mainly genes located on chromosomes 3 and 5 gained regions. We also observed one gene in the top-20 list, HSP90AA1, located on chromosome 14. The HSP90AA1 gene (generally referred to as HSP90), located on 14q32.2, was the only gene in this region with significantly reduced expression in patients affected by loss of this region (P = 0.05). These observations prompted us to investigate this locus in more detail.</p>


<h4>Genomic aberrations on 14q and HSP90AA1 gene expression correlation with survival</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>We investigated the correlation of the recurrent tight deletion at region 14q32.2-33, with survival. Interestingly, patients in whom this region was deleted had an improved overall survival (OS) compared to patients harboring a normal gene dosage at this locus (5 year OS 69% vs. 41%, P = 0.004-<a href="#pone-0001722-g002">Figure 2A</a>).</p>
<div class="figure" id="pone-0001722-g002"><div class="img"><a name="pone-0001722-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Loss of 14q32.2-32.33 chromosomal region and HSP90 expression in relation with survival.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>(A) Kaplan-Meier curves for overall survival are shown for 29 patients in relation to gene dosage in chromosome region 14q32.33. (B) Overall survival for 29 patients in relation to HSP90 expression. Low expression was defined as expression lower than the median of the total 32 samples, “normal” expression was defined as higher than the median of 32 samples. Three of 32 patients included in the analysis of gene dosage and expression were excluded from the survival analysis because of a survival time of less than 30 days.</p>
<span>doi:10.1371/journal.pone.0001722.g002</span></div><a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2"></a><p>In order to investigate HSP90 expression in relation with survival, we divided the 32 patients into two groups based on their survival status two years after tumor resection. About half of the patients were categorized as “high-risk” and half as “low-risk”. To identify whether both risk groups could be discriminated using gene expression of HSP90, we constructed Kaplan Meier survival estimates for two equally large groups with “low” and “normal”, based on the median HSP90 expression. Low expression of HSP90 was associated with better overall survival (5 year OS 70% vs. 40%, P = 0.13–<a href="#pone-0001722-g002">Figure 2B</a>) although differences between the two groups were initially not significant due probably to a combination of a low magnitude of the difference and a low number of patients analyzed.</p>


<h4>Technical validation of 14q deletion and HSP90 expression</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>To validate the deletion observed in region 14q32.2-33 we performed multiplex ligation dependent probe amplification <a href="#pone.0001722-Schouten1">[13]</a> (MLPA) analysis using a subtelomere probeset containing a probe in region 14q32.33. The correlation coefficient (R<sup>2</sup>) between the loss of this area detected by array CGH and by MLPA was 0.439.</p>
<a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2"></a><p>To validate the HSP90 expression data obtained with microarrays we performed quantitative RT PCR using the Taqman® technology. A good correlation between the expression of HSP90 measured with the two different techniques was observed (R<sup>2</sup> = 0.6431).</p>


<h4>Validation of HSP90 expression and relation with survival in independent patient series</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>To further investigate the association between low HSP90 expression and NSCLC patient prognosis, we used three independent validation sets of NSCLC patients. In all three patient sets, the “low-risk”/“high-risk” patient distribution across patient cohorts was approximately two-thirds vs. one-third. Therefore, we used the 33-percentile of HSP90 expression as cut off for separation of patients with “normal” (i.e. high-risk) and “low” (i.e. low-risk) expression. For all three validation sets, low expression of HSP90 was correlated with improved overall survival. This correlation was significant for the first and third validation sets (P = 0.003 and P = 0.04), and borderline significant for the second set (P = 0.07) (<a href="#pone-0001722-g003">Figure 3</a>). Multivariate analysis revealed that HSP90 prognostic value was independent from the stage, histologic subtype, age and gender of patients (<a href="#pone-0001722-t003">Table 3</a>).</p>
<div class="figure" id="pone-0001722-g003"><div class="img"><a name="pone-0001722-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>HSP90 expression and survival in three validation sets of NSCLC patients.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>Overall survival for (A) 140 patients with NSCLC, validation set 1 (B) 111 NSCLC patients, validation set 2 and (C) 54 patients with NSCLC, validation set 3. The cut off for distinction between low and “normal” expression was based on the 33-percentile of expression values.</p>
<span>doi:10.1371/journal.pone.0001722.g003</span></div><div class="figure" id="pone-0001722-t003"><div class="img"><a name="pone-0001722-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Multivariate cox analysis of HSP90 expression and survival</span></strong></p><span>doi:10.1371/journal.pone.0001722.t003</span></div>

<h4>Validation of Hsp90 as a viable molecular target in a panel of NSCLC cell lines</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>Hsp90 is a molecular chaperone that stabilizes several oncoproteins, including EGFR, and constitutes a novel potential target for anticancer therapy. The data above showed that Hsp90 expression level is a prognostic indicator of long-term survival in a large series of NSCLC patients, and suggest that Hsp90 inhibitors may have broader utility in this disease than previously recognized. To examine this possibility, we tested whether pharmacologic inhibition of Hsp90 function would impact the <em>in vitro</em> cell growth of a panel of NSCLC cell lines. The growth of these cell lines, all bearing wild-type EGFR, was profoundly inhibited, in a dose- and time-dependent manner, by sub-micromolar concentrations of 17-AAG, an Hsp90 inhibitor <a href="#pone.0001722-Schulte1">[14]</a> currently in phase II clinical trial (<a href="#pone-0001722-g004">Figure 4</a>). At 72 hours, the IC50 was below 50 nM 17-AAG in all cases, and higher drug concentrations consistently resulted in marked cytotoxicity.</p>
<div class="figure" id="pone-0001722-g004"><div class="img"><a name="pone-0001722-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001722" data-uri="info:doi/10.1371/journal.pone.0001722.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001722.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001722.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001722.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Sensitivity of a panel of wild type EGFR-expressing NSCLC cell lines to the Hsp90 inhibitor 17-AAG.</span></strong></p><a id="article1.body1.sec3.sec5.fig1.caption1.p1" name="article1.body1.sec3.sec5.fig1.caption1.p1"></a><p>(A–D) time- and dose-dependent inhibition of the in vitro growth of H460, H157, H441, and A549 NSCLC cell lines following exposure to 17-AAG. Cells were seeded at 105/well, and viable cell number was determined on subsequent days as described in <a href="#s2">Methods</a>. 17-AAG concentrations at (H441) or above (A549, H460 &amp; H157) 30 nM uniformly resulted in time-dependent loss of cell viability. The IC50 value of 17-AAG (continuous exposure for 72 h) for each cell line is as follows: H460 = 30 nM, H157 = 15 nM, H441 = 8 nM, and A549 = 20 nM.</p>
<span>doi:10.1371/journal.pone.0001722.g004</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Based on array-CGH data in NSCLC, it has been shown that multiple molecular carcinogenesis pathways exist that are most likely related to gender and smoking habits <a href="#pone.0001722-Shibata1">[15]</a>. Furthermore, it was shown that there is a large overlap between aberrations observed in the adenocarcinoma and squamous cell carcinoma subtype, except for 3q gains which seem to be more specific for the squamous cell carcinoma subtype <a href="#pone.0001722-Tonon1">[16]</a>. Various gene expression signatures have been correlated to survival of NSCLC patients <a href="#pone.0001722-Beer1">[17]</a>–<a href="#pone.0001722-Chen1">[19]</a>. In addition, molecular studies have allowed the development of personalized treatment approaches in several tumor types <a href="#pone.0001722-Lynch1">[20]</a>–<a href="#pone.0001722-Slamon1">[22]</a>. However, it is likely that many cancer-related target genes have not been identified yet. In this regard, integrated genome wide screening of copy number changes and gene expression using microarrays has been recently carried out in various tumor types to identify genes whose expression is affected by gene dosage <a href="#pone.0001722-Chin1">[4]</a>, <a href="#pone.0001722-Balsara2">[23]</a>–<a href="#pone.0001722-Tay1">[26]</a>. These studies aim to identify novel cancer-related genes and to define novel biomarkers for response or prognostic signatures. In both NSCLC and ductal pancreatic cancer, two focal amplifications of 8p12 and 20q11 have been studied in detail leading to two candidate genes (WHSC1L1 and TPX2) important in these diseases <a href="#pone.0001722-Tonon1">[16]</a></p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>We here performed an integrated genome wide screening of gene copy number changes and gene expression in 32 radically resected NSCLC patients, in order to identify novel NSCLC-related genes. By using ACE-it, a novel informatics tool for integration of gene dosage and gene expression data, we identified 359 transcripts to be significantly affected by copy number. A cox survival analysis on all 359 genes revealed no significant relation after multiple testing. The top list of genes related to survival mainly included genes residing on gained regions 3q and 5p. These regions cover many genes and to pinpoint the gene of most importance is a challenging task. Further investigations should elucidate the importance of these genes in relation to NSCLC, in particular of those in the top list of correlation with survival such as SLC45A2, WDR70 and NIPBL (see supplementary <a href="#pone.0001722.s001">table S1</a>). In this paper we focused on the recurrent deletion on chromosome 14 and the gene HSP90, which was also in the top list of relation with survival and not previously investigated in detail. Deletion of region 14q32.2-33 was correlated with improved survival, further suggesting that it may contain one or more genes related to NSCLC progression. Deletion of this region has been previously described by one group reporting genomic aberrations in NSCLC, but was not investigated in further detail <a href="#pone.0001722-Choi1">[27]</a>. Out of the 109 genes mapping to the 14q32.2-33 region, HSP90 was the only gene with significantly lower expression in patients harboring the 14q32.2-33 deletion. In the initial series of 29 patients (3 patients excluded from survival analysis), we observed improved survival in patients with lower levels of HSP90. The association between HSP90 expression levels and NSCLC patient prognosis was confirmed to be significant in three independent validation sets of NSCLC patients. Multivariate analysis including stage, histology, age and gender showed that HSP90 remained independently related to survival.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>A critical issue in defining “low” and “normal” expression is the choice of an appropriate cut off value. In the initial analyses we used the median of expression ratios as cut off between “low” and “normal” expression, since the low-risk and high-risk separation of patients was equal. However, in the validation sets the low-risk and high-risk survival groups were not equally balanced (two thirds versus one third). Consequently the cut off values used in these data sets was not the median value, but the 33-percentile.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>In this study, using a genome wide integrative analysis of gene copy number and expression we were able to identify expression of HSP90 as an important gene in early stage NSCLC patients. HSP90 is a chaperone protein involved in the stabilization of multiple oncoproteins such as EGFR, Her-2 and Akt <a href="#pone.0001722-Burrows1">[28]</a>. Recent work has shown that HSP90 plays a role in maintaining the active conformation of EGFR and in particular EGFR mutants <a href="#pone.0001722-Yang1">[29]</a>, <a href="#pone.0001722-Shimamura1">[30]</a>. We show here that several NSCLC cell lines bearing wild-type EGFR are sensitive to HSP90 inhibition, indicating that the inhibitory effect of 17-AAG can not be solely attributed to mutant EGFR. HSP90 has been recently recognized as a potential cancer therapeutic target and investigations of HSP90 inhibitors are ongoing <a href="#pone.0001722-Cullman1">[31]</a>, <a href="#pone.0001722-Zhang1">[32]</a>. In this regard, glioblastoma cells overexpressing EGFR, but resistant to inhibition by EGFR kinase inhibitors, were sensitive to HSP90 inhibition <a href="#pone.0001722-Thomas1">[33]</a>. Therefore, while Hsp90 may be required to stabilize over-expressed or mutated EGFR, our data support a more wide-ranging and complex role for Hsp90 in mediating NSCLC growth and survival. The low nanomolar sensitivity observed in the 4 cell lines tested in our experiments, is in agreement with other published reports of highly 17-AAG sensitive tumor cell lines <a href="#pone.0001722-BragaBasaria1">[34]</a>–<a href="#pone.0001722-Zsebik1">[36]</a>. These concentrations are readily achievable in patients for prolonged time periods using current scheduling and dosing regimens <a href="#pone.0001722-Xu1">[37]</a>.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>In summary, the observation that HSP90 expression level is a prognostic factor for NSCLC patient survival (independent of EGFR mutational status), coupled with the extreme sensitivity of EGFR wild type NSCLC cells to the Hsp90 inhibitor 17-AAG, suggests that Hsp90 inhibitors may have greater clinical utility in NSCLC than has been previously considered and warrants further investigation of the dependence of other proto-oncogenes on this chaperone protein in NSCLC.</p>
</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0001722"></div><a name="pone.0001722.s001" id="pone.0001722.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001722.s001">Table S1. </a></strong></p><p class="siDoi">doi:10.1371/journal.pone.0001722.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="postSiDOI">(0.03 MB PDF)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank the European lung cancer consortium for providing microarray gene expression data of the 140 independent NSCLC patients; Netherlands Cancer Institute: Sjaak Burgers, Tony van de Velde; Medical University of Gdansk: Jacek Jassem, Amelia Szymanowska, Marcin Skrzypski, Barbara Szostakiewicz, Witold Rzyman; Medical University of Bialystok: Jerzy Laudanski, Miroslaw Kozlowski, Lech Chyczewski; Thoraxklinik Heidelberg: Michael Meister, Philipp A. Schnabel, Henrik Dienemann and Hans Hoffman. We also give our special thanks to Sjoerd Vosse (Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) for helpful bioinformatics discussions and to Hans Gille (Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands) for performing MLPA analysis.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: BY GM GG JR MG. Performed the experiments: KF KB MG. Analyzed the data: PR WM MG. Contributed reagents/materials/analysis tools: EJ JN TM Nv ES LN. Wrote the paper: BY PR GM GG JR ES LN MG. Other: Designed the study: GG.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001722-Jemal1" id="pone.0001722-Jemal1"></a>Jemal A, Siegel R, Ward E, Murray T, Xu JQ, et al.  (2006) Cancer statistics, 2006. Ca-A Cancer Journal for Clinicians  56: 106–130.  <ul class="find" data-citedArticleID="1067284" data-doi="10.3322/canjclin.56.2.106"><li><a href="http://dx.doi.org/10.3322/canjclin.56.2.106" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cancer+statistics%2C+2006." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cancer+statistics%2C+2006.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001722-Sekido1" id="pone.0001722-Sekido1"></a>Sekido Y, Fong KM, Minna JD (2003) Molecular genetics of lung cancer. Annual Review of Medicine-Selected Topics in the Clinical Sciences  54: 73–87.  <ul class="find" data-citedArticleID="1067300" data-doi="10.1146/annurev.med.54.101601.152202"><li><a href="http://dx.doi.org/10.1146/annurev.med.54.101601.152202" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+genetics+of+lung+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+genetics+of+lung+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001722-Balsara1" id="pone.0001722-Balsara1"></a>Balsara BR, Testa JR (2002) Chromosomal imbalances in human lung cancer. Oncogene  21: 6877–6883.  <ul class="find" data-citedArticleID="1067260" data-doi="10.1038/sj.onc.1205836"><li><a href="http://dx.doi.org/10.1038/sj.onc.1205836" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chromosomal+imbalances+in+human+lung+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chromosomal+imbalances+in+human+lung+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001722-Chin1" id="pone.0001722-Chin1"></a>Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al.  (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell  10: 529–541.  <ul class="find" data-citedArticleID="1067276" data-doi="10.1016/j.ccr.2006.10.009"><li><a href="http://dx.doi.org/10.1016/j.ccr.2006.10.009" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genomic+and+transcriptional+aberrations+linked+to+breast+cancer+pathophysiologies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genomic+and+transcriptional+aberrations+linked+to+breast+cancer+pathophysiologies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001722-vandeWiel1" id="pone.0001722-vandeWiel1"></a>van de Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, et al.  (2007) CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics  23: 892–894.  <ul class="find" data-citedArticleID="1067328" data-doi="10.1093/bioinformatics/btm030"><li><a href="http://dx.doi.org/10.1093/bioinformatics/btm030" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CGHcall%3A+calling+aberrations+for+array+CGH+tumor+profiles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CGHcall%3A+calling+aberrations+for+array+CGH+tumor+profiles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001722-vanWieringen1" id="pone.0001722-vanWieringen1"></a>van Wieringen WN, Belien JAM, Vosse SJ, Achame EM, et al.  (2006) ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data. Bioinformatics  22: 1919–1920.  <ul class="find" data-citedArticleID="1067326" data-doi="10.1093/bioinformatics/btl269"><li><a href="http://dx.doi.org/10.1093/bioinformatics/btl269" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ACE-it%3A+a+tool+for+genome-wide+integration+of+gene+dosage+and+RNA+expression+data." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ACE-it%3A+a+tool+for+genome-wide+integration+of+gene+dosage+and+RNA+expression+data.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001722-Bild1" id="pone.0001722-Bild1"></a>Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al.  (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature  439: 353–357.  <ul class="find" data-citedArticleID="1067268" data-doi="10.1038/nature04296"><li><a href="http://dx.doi.org/10.1038/nature04296" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Oncogenic+pathway+signatures+in+human+cancers+as+a+guide+to+targeted+therapies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Oncogenic+pathway+signatures+in+human+cancers+as+a+guide+to+targeted+therapies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001722-Lu1" id="pone.0001722-Lu1"></a>Lu Y, Lemon W, Liu PY, Yi YJ, Morrison C, et al.  (2006) A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. Plos Medicine  3: 2229–2243.  <ul class="find" data-citedArticleID="1067286" data-doi="10.1371/journal.pmed.0030467"><li><a href="http://dx.doi.org/10.1371/journal.pmed.0030467" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+gene+expression+signature+predicts+survival+of+patients+with+stage+I+non-small+cell+lung+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+gene+expression+signature+predicts+survival+of+patients+with+stage+I+non-small+cell+lung+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001722-vandenIJssel1" id="pone.0001722-vandenIJssel1"></a>van den IJssel P, Tijssen M, Chin SF, Eijk P, Carvalho B, et al.  (2005) Human and mouse oligonucleotide-based array CGH. Nucleic Acids Research  33:   <ul class="find" data-citedArticleID="1067332" data-doi="10.1093/nar/gni191"><li><a href="http://dx.doi.org/10.1093/nar/gni191" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+and+mouse+oligonucleotide-based+array+CGH." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+and+mouse+oligonucleotide-based+array+CGH.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001722-Glas1" id="pone.0001722-Glas1"></a>Glas AM, Floore A, Delahaye LJMJ, Witteveen AT, Pover RCF, et al.  (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. Bmc Genomics  7:   <ul class="find" data-citedArticleID="1067282"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Converting+a+breast+cancer+microarray+signature+into+a+high-throughput+diagnostic+test.&amp;auth=&amp;atitle=Converting+a+breast+cancer+microarray+signature+into+a+high-throughput+diagnostic+test." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Converting+a+breast+cancer+microarray+signature+into+a+high-throughput+diagnostic+test." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Converting+a+breast+cancer+microarray+signature+into+a+high-throughput+diagnostic+test.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001722-vandeWiel2" id="pone.0001722-vandeWiel2"></a>van de Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, et al.  (2007) CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics  23: 892–894.  <ul class="find" data-citedArticleID="1067330" data-doi="10.1093/bioinformatics/btm030"><li><a href="http://dx.doi.org/10.1093/bioinformatics/btm030" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CGHcall%3A+calling+aberrations+for+array+CGH+tumor+profiles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CGHcall%3A+calling+aberrations+for+array+CGH+tumor+profiles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001722-Benjamini1" id="pone.0001722-Benjamini1"></a>Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate-A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological  57: 289–300.  <ul class="find" data-citedArticleID="1067266"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Controlling+the+False+Discovery+Rate-A+Practical+and+Powerful+Approach+to+Multiple+Testing.&amp;auth=&amp;atitle=Controlling+the+False+Discovery+Rate-A+Practical+and+Powerful+Approach+to+Multiple+Testing." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Controlling+the+False+Discovery+Rate-A+Practical+and+Powerful+Approach+to+Multiple+Testing." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Controlling+the+False+Discovery+Rate-A+Practical+and+Powerful+Approach+to+Multiple+Testing.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001722-Schouten1" id="pone.0001722-Schouten1"></a>Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, et al.  (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Research  30: e57.  <ul class="find" data-citedArticleID="1067296" data-doi="10.1093/nar/gnf056"><li><a href="http://dx.doi.org/10.1093/nar/gnf056" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Relative+quantification+of+40+nucleic+acid+sequences+by+multiplex+ligation-dependent+probe+amplification." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Relative+quantification+of+40+nucleic+acid+sequences+by+multiplex+ligation-dependent+probe+amplification.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001722-Schulte1" id="pone.0001722-Schulte1"></a>Schulte TW, Neckers LM (1998) The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin. Cancer Chemotherapy and Pharmacology  42: 273–279.  <ul class="find" data-citedArticleID="1067298" data-doi="10.1007/s002800050817"><li><a href="http://dx.doi.org/10.1007/s002800050817" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001722-Shibata1" id="pone.0001722-Shibata1"></a>Shibata T, Uryu S, Kokubu A, Hosoda F, Ohki M, et al.  (2005) Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: Its association with clinicopathologic features. Clinical Cancer Research  11: 6177–6185.  <ul class="find" data-citedArticleID="1067302" data-doi="10.1158/1078-0432.ccr-05-0293"><li><a href="http://dx.doi.org/10.1158/1078-0432.ccr-05-0293" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genetic+classification+of+lung+adenocarcinoma+based+on+array-based+comparative+genomic+hybridization+analysis%3A+Its+association+with+clinicopathologic+features." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genetic+classification+of+lung+adenocarcinoma+based+on+array-based+comparative+genomic+hybridization+analysis%3A+Its+association+with+clinicopathologic+features.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001722-Tonon1" id="pone.0001722-Tonon1"></a>Tonon G, Wong KK, Maulik G, Brennan C, Feng B, et al.  (2005) High-resolution genomic profiles of human lung cancer. Proceedings of the National Academy of Sciences of the United States of America  102: 9625–9630.  <ul class="find" data-citedArticleID="1067312" data-doi="10.1073/pnas.0504126102"><li><a href="http://dx.doi.org/10.1073/pnas.0504126102" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=High-resolution+genomic+profiles+of+human+lung+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22High-resolution+genomic+profiles+of+human+lung+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001722-Beer1" id="pone.0001722-Beer1"></a>Beer DG, Kardia SLR, Huang CC, Giordano TJ, Levin AM, et al.  (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine  8: 816–824.  <ul class="find" data-citedArticleID="1067264" data-doi="10.1038/nm733"><li><a href="http://dx.doi.org/10.1038/nm733" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene-expression+profiles+predict+survival+of+patients+with+lung+adenocarcinoma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene-expression+profiles+predict+survival+of+patients+with+lung+adenocarcinoma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001722-Wigle1" id="pone.0001722-Wigle1"></a>Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, et al.  (2002) Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Research  62: 3005–3008.  <ul class="find" data-citedArticleID="1067314"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Molecular+profiling+of+non-small+cell+lung+cancer+and+correlation+with+disease-free+survival.&amp;auth=&amp;atitle=Molecular+profiling+of+non-small+cell+lung+cancer+and+correlation+with+disease-free+survival." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+profiling+of+non-small+cell+lung+cancer+and+correlation+with+disease-free+survival." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+profiling+of+non-small+cell+lung+cancer+and+correlation+with+disease-free+survival.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001722-Chen1" id="pone.0001722-Chen1"></a>Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al.  (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. New England Journal of Medicine  356: 11–20.  <ul class="find" data-citedArticleID="1067274" data-doi="10.1056/nejmoa060096"><li><a href="http://dx.doi.org/10.1056/nejmoa060096" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+five-gene+signature+and+clinical+outcome+in+non-small-cell+lung+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+five-gene+signature+and+clinical+outcome+in+non-small-cell+lung+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001722-Lynch1" id="pone.0001722-Lynch1"></a>Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, et al.  (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine  350: 2129–2139.  <ul class="find" data-citedArticleID="1067288" data-doi="10.1056/nejmoa040938"><li><a href="http://dx.doi.org/10.1056/nejmoa040938" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001722-Pao1" id="pone.0001722-Pao1"></a>Pao W, Wang TY, Riely GJ, Miller VA, Pan QL, et al.  (2005) KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. Plos Medicine  2: 57–61.  <ul class="find" data-citedArticleID="1067290" data-doi="10.1371/journal.pmed.0020017"><li><a href="http://dx.doi.org/10.1371/journal.pmed.0020017" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=KRAS+mutations+and+primary+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22KRAS+mutations+and+primary+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001722-Slamon1" id="pone.0001722-Slamon1"></a>Slamon D, Pegram M (2001) Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials. Seminars in Oncology  28: 13–19.  <ul class="find" data-citedArticleID="1067306" data-doi="10.1053/sonc.2001.22812"><li><a href="http://dx.doi.org/10.1053/sonc.2001.22812" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Rationale+for+trastuzumab+%28Herceptin%29+in+adjuvant+breast+cancer+trials." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Rationale+for+trastuzumab+%28Herceptin%29+in+adjuvant+breast+cancer+trials.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001722-Balsara2" id="pone.0001722-Balsara2"></a>Balsara BR, Sonoda G, duManoir S, Siegfried JM, Gabrielson E, et al.  (1997) Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Research  57: 2116–2120.  <ul class="find" data-citedArticleID="1067262"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Comparative+genomic+hybridization+analysis+detects+frequent%2C+often+high-level%2C+overrepresentation+of+DNA+sequences+at+3q%2C+5p%2C+7p%2C+and+8q+in+human+non-small+cell+lung+carcinomas.&amp;auth=&amp;atitle=Comparative+genomic+hybridization+analysis+detects+frequent%2C+often+high-level%2C+overrepresentation+of+DNA+sequences+at+3q%2C+5p%2C+7p%2C+and+8q+in+human+non-small+cell+lung+carcinomas." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparative+genomic+hybridization+analysis+detects+frequent%2C+often+high-level%2C+overrepresentation+of+DNA+sequences+at+3q%2C+5p%2C+7p%2C+and+8q+in+human+non-small+cell+lung+carcinomas." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparative+genomic+hybridization+analysis+detects+frequent%2C+often+high-level%2C+overrepresentation+of+DNA+sequences+at+3q%2C+5p%2C+7p%2C+and+8q+in+human+non-small+cell+lung+carcinomas.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001722-Pollack1" id="pone.0001722-Pollack1"></a>Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, et al.  (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences of the United States of America  99: 12963–12968.  <ul class="find" data-citedArticleID="1067292" data-doi="10.1073/pnas.162471999"><li><a href="http://dx.doi.org/10.1073/pnas.162471999" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Microarray+analysis+reveals+a+major+direct+role+of+DNA+copy+number+alteration+in+the+transcriptional+program+of+human+breast+tumors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Microarray+analysis+reveals+a+major+direct+role+of+DNA+copy+number+alteration+in+the+transcriptional+program+of+human+breast+tumors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001722-Redon1" id="pone.0001722-Redon1"></a>Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, et al.  (2001) A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Research  61: 4122–4129.  <ul class="find" data-citedArticleID="1067294"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=A+simple+specific+pattern+of+chromosomal+aberrations+at+early+stages+of+head+and+neck+squamous+cell+carcinomas%3A+PIK3CA+but+not+p63+gene+as+a+likely+target+of+3q26-qter+gains.&amp;auth=&amp;atitle=A+simple+specific+pattern+of+chromosomal+aberrations+at+early+stages+of+head+and+neck+squamous+cell+carcinomas%3A+PIK3CA+but+not+p63+gene+as+a+likely+target+of+3q26-qter+gains." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+simple+specific+pattern+of+chromosomal+aberrations+at+early+stages+of+head+and+neck+squamous+cell+carcinomas%3A+PIK3CA+but+not+p63+gene+as+a+likely+target+of+3q26-qter+gains." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+simple+specific+pattern+of+chromosomal+aberrations+at+early+stages+of+head+and+neck+squamous+cell+carcinomas%3A+PIK3CA+but+not+p63+gene+as+a+likely+target+of+3q26-qter+gains.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001722-Tay1" id="pone.0001722-Tay1"></a>Tay ST, Leong SH, Yu K, Aggarwal A, Tan SY, et al.  (2003) A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Research  63: 3309–3316.  <ul class="find" data-citedArticleID="1067308"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=A+combined+comparative+genomic+hybridization+and+expression+microarray+analysis+of+gastric+cancer+reveals+novel+molecular+subtypes.&amp;auth=&amp;atitle=A+combined+comparative+genomic+hybridization+and+expression+microarray+analysis+of+gastric+cancer+reveals+novel+molecular+subtypes." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+combined+comparative+genomic+hybridization+and+expression+microarray+analysis+of+gastric+cancer+reveals+novel+molecular+subtypes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+combined+comparative+genomic+hybridization+and+expression+microarray+analysis+of+gastric+cancer+reveals+novel+molecular+subtypes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001722-Choi1" id="pone.0001722-Choi1"></a>Choi JS, Zheng LT, Ha E, Lim YJ, Kim YH, et al.  (2006) Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung  184: 355–362.  <ul class="find" data-citedArticleID="1067278" data-doi="10.1007/s00408-006-0009-0"><li><a href="http://dx.doi.org/10.1007/s00408-006-0009-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparative+genomic+hybridization+array+analysis+and+real-time+PCR+reveals+genomic+copy+number+alteration+for+lung+adenocarcinomas." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparative+genomic+hybridization+array+analysis+and+real-time+PCR+reveals+genomic+copy+number+alteration+for+lung+adenocarcinomas.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001722-Burrows1" id="pone.0001722-Burrows1"></a>Burrows F, Zhang H, Kamal A (2004) Hsp90 activation and cell cycle regulation. Cell Cycle  3: 1530–1536.  <ul class="find" data-citedArticleID="1067272" data-doi="10.4161/cc.3.12.1277"><li><a href="http://dx.doi.org/10.4161/cc.3.12.1277" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hsp90+activation+and+cell+cycle+regulation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hsp90+activation+and+cell+cycle+regulation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001722-Yang1" id="pone.0001722-Yang1"></a>Yang SC, Qu S, Perez-Tores M, Sawai A, Rosen N, et al.  (2006) Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Cancer Research  66: 6990–6997.  <ul class="find" data-citedArticleID="1067318" data-doi="10.1158/0008-5472.can-06-1042"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-06-1042" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+with+HSP90+inhibits+Cbl-mediated+down-regulation+of+mutant+epidermal+growth+factor+receptors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+with+HSP90+inhibits+Cbl-mediated+down-regulation+of+mutant+epidermal+growth+factor+receptors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001722-Shimamura1" id="pone.0001722-Shimamura1"></a>Shimamura T, Lowell AM, Engelman JA, Shapiro GI (2005) Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Research  65: 6401–6408.  <ul class="find" data-citedArticleID="1067304" data-doi="10.1158/0008-5472.can-05-0933"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-05-0933" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Epidermal+growth+factor+receptors+harboring+kinase+domain+mutations+associate+with+the+heat+shock+protein+90+chaperone+and+are+destabilized+following+exposure+to+geldanamycins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Epidermal+growth+factor+receptors+harboring+kinase+domain+mutations+associate+with+the+heat+shock+protein+90+chaperone+and+are+destabilized+following+exposure+to+geldanamycins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001722-Cullman1" id="pone.0001722-Cullman1"></a>Cullman SB, Whitesell L (2006) Heat shock protein 90: A unique chemotherapeutic target. Seminars in Oncology  33: 457–465.  <ul class="find" data-citedArticleID="1067280" data-doi="10.1053/j.seminoncol.2006.04.001"><li><a href="http://dx.doi.org/10.1053/j.seminoncol.2006.04.001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Heat+shock+protein+90%3A+A+unique+chemotherapeutic+target." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Heat+shock+protein+90%3A+A+unique+chemotherapeutic+target.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001722-Zhang1" id="pone.0001722-Zhang1"></a>Zhang H, Burrows F (2004) Targeting multiple signal transduction pathways through inhibition of Hsp90. Journal of Molecular Medicine-Jmm  82: 488–499.  <ul class="find" data-citedArticleID="1067322" data-doi="10.1007/s00109-004-0549-9"><li><a href="http://dx.doi.org/10.1007/s00109-004-0549-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeting+multiple+signal+transduction+pathways+through+inhibition+of+Hsp90." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeting+multiple+signal+transduction+pathways+through+inhibition+of+Hsp90.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001722-Thomas1" id="pone.0001722-Thomas1"></a>Thomas CY, Stallings-Mann M, Zang H, Yang YC, Burrows F, et al.  (2003) Glioblastoma (GBM) cells that overexpress epidermal growth factor receptors (EGFR) are sensitive to HSP90 but not EGFR kinase inhibitors. Clinical Cancer Research  9: 6098S.  <ul class="find" data-citedArticleID="1067310"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Glioblastoma+%28GBM%29+cells+that+overexpress+epidermal+growth+factor+receptors+%28EGFR%29+are+sensitive+to+HSP90+but+not+EGFR+kinase+inhibitors.&amp;auth=&amp;atitle=Glioblastoma+%28GBM%29+cells+that+overexpress+epidermal+growth+factor+receptors+%28EGFR%29+are+sensitive+to+HSP90+but+not+EGFR+kinase+inhibitors." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Glioblastoma+%28GBM%29+cells+that+overexpress+epidermal+growth+factor+receptors+%28EGFR%29+are+sensitive+to+HSP90+but+not+EGFR+kinase+inhibitors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Glioblastoma+%28GBM%29+cells+that+overexpress+epidermal+growth+factor+receptors+%28EGFR%29+are+sensitive+to+HSP90+but+not+EGFR+kinase+inhibitors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001722-BragaBasaria1" id="pone.0001722-BragaBasaria1"></a>Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, et al.  (2004) 17-allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. Journal of Clinical Endocrinology and Metabolism  89: 2982–2988.  <ul class="find" data-citedArticleID="1067270" data-doi="10.1210/jc.2003-031767"><li><a href="http://dx.doi.org/10.1210/jc.2003-031767" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=17-allylamino-17-demethoxygeldanamycin+activity+against+thyroid+cancer+cell+lines+correlates+with+heat+shock+protein+90+levels." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%2217-allylamino-17-demethoxygeldanamycin+activity+against+thyroid+cancer+cell+lines+correlates+with+heat+shock+protein+90+levels.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001722-Yang2" id="pone.0001722-Yang2"></a>Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, et al.  (2001) Disruption of the EF-2 kinase/Hsp90 protein complex: A possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Research  61: 4010–4016.  <ul class="find" data-citedArticleID="1067320"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Disruption+of+the+EF-2+kinase%2FHsp90+protein+complex%3A+A+possible+mechanism+to+inhibit+glioblastoma+by+geldanamycin.&amp;auth=&amp;atitle=Disruption+of+the+EF-2+kinase%2FHsp90+protein+complex%3A+A+possible+mechanism+to+inhibit+glioblastoma+by+geldanamycin." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Disruption+of+the+EF-2+kinase%2FHsp90+protein+complex%3A+A+possible+mechanism+to+inhibit+glioblastoma+by+geldanamycin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Disruption+of+the+EF-2+kinase%2FHsp90+protein+complex%3A+A+possible+mechanism+to+inhibit+glioblastoma+by+geldanamycin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001722-Zsebik1" id="pone.0001722-Zsebik1"></a>Zsebik B, Citri A, Isola J, Yarden Y, Szollosi J, et al.  (2006) Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1. Immunology Letters  104: 146–155.  <ul class="find" data-citedArticleID="1067324" data-doi="10.1016/j.imlet.2005.11.018"><li><a href="http://dx.doi.org/10.1016/j.imlet.2005.11.018" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hsp90+inhibitor+17-AAG+reduces+ErbB2+levels+and+inhibits+proliferation+of+the+trastuzumab+resistant+breast+tumor+cell+line+JIMT-1." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hsp90+inhibitor+17-AAG+reduces+ErbB2+levels+and+inhibits+proliferation+of+the+trastuzumab+resistant+breast+tumor+cell+line+JIMT-1.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001722-Xu1" id="pone.0001722-Xu1"></a>Xu WP, Neckers L (2007) Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clinical Cancer Research  13: 1625–1629.  <ul class="find" data-citedArticleID="1067316" data-doi="10.1158/1078-0432.ccr-06-2966"><li><a href="http://dx.doi.org/10.1158/1078-0432.ccr-06-2966" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeting+the+molecular+chaperone+heat+shock+protein+90+provides+a+multifaceted+effect+on+diverse+cell+signaling+pathways+of+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeting+the+molecular+chaperone+heat+shock+protein+90+provides+a+multifaceted+effect+on+diverse+cell+signaling+pathways+of+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.XML" value="99920"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.PDF" value="495568"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t001.PNG_L" value="159080"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t001.PNG_M" value="93672"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t001.PNG_S" value="13867"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t001.TIF" value="922540"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t001.PNG_I" value="28468"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g001.PNG_L" value="338804"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g001.PNG_M" value="71044"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g001.PNG_S" value="8772"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g001.TIF" value="1478168"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g001.PNG_I" value="26733"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t002.PNG_L" value="247782"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t002.PNG_M" value="115064"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t002.PNG_S" value="24309"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t002.TIF" value="1312194"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t002.PNG_I" value="179239"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g002.PNG_L" value="158961"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g002.PNG_M" value="35509"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g002.PNG_S" value="5638"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g002.TIF" value="435134"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g002.PNG_I" value="14353"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g003.PNG_L" value="256592"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g003.PNG_M" value="52903"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g003.PNG_S" value="5853"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g003.TIF" value="512632"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g003.PNG_I" value="20635"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t003.PNG_L" value="78155"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t003.PNG_M" value="114759"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t003.PNG_S" value="16297"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t003.TIF" value="346350"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.t003.PNG_I" value="39566"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g004.PNG_L" value="605319"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g004.PNG_M" value="99384"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g004.PNG_S" value="8843"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g004.TIF" value="1061332"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.g004.PNG_I" value="36392"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001722.s001.PDF" value="30413"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001722&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001722" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001722&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001722&volume=&issue=&title=Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target&author_name=Mari%C3%ABlle%20I.%20Gallegos%20Ruiz%2C%20Karijn%20Floor%2C%20Paul%20Roepman%2C%20Jos%C3%A9%20A.%20Rodriguez%2C%20Gerrit%20A.%20Meijer%2C%20Wolter%20J.%20Mooi%2C%20Ewa%20Jassem%2C%20Jacek%20Niklinski%2C%20Thomas%20Muley%2C%20Nico%20van%20Zandwijk%2C%20Egbert%20F.%20Smit%2C%20Kristin%20Beebe%2C%20Len%20Neckers%2C%20Bauke%20Ylstra%2C%20Giuseppe%20Giaccone&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001722" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722&amp;t=Integration%20of%20Gene%20Dosage%20and%20Gene%20Expression%20in%20Non-Small%20Cell%20Lung%20Cancer%2C%20Identification%20of%20HSP90%20as%20Potential%20Target" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722&title=Integration%20of%20Gene%20Dosage%20and%20Gene%20Expression%20in%20Non-Small%20Cell%20Lung%20Cancer%2C%20Identification%20of%20HSP90%20as%20Potential%20Target&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722&amp;title=Integration%20of%20Gene%20Dosage%20and%20Gene%20Expression%20in%20Non-Small%20Cell%20Lung%20Cancer%2C%20Identification%20of%20HSP90%20as%20Potential%20Target" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001722&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001722';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Integration%20of%20Gene%20Dosage%20and%20Gene%20Expression%20in%20Non-Small%20Cell%20Lung%20Cancer%2C%20Identification%20of%20HSP90%20as%20Potential%20Target http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001722" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001722" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">













          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Array+CGH%22" title="Search for articles in the subject area:'Array CGH'"><div class="flagText">Array CGH</div></a>
              <div data-categoryid="41443" data-articleid="26270"
                   data-categoryname="Array CGH"
                   class="flagImage" title="Flag 'Array CGH' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Chromosomes%22" title="Search for articles in the subject area:'Chromosomes'"><div class="flagText">Chromosomes</div></a>
              <div data-categoryid="17251" data-articleid="26270"
                   data-categoryname="Chromosomes"
                   class="flagImage" title="Flag 'Chromosomes' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Comparative+genomics%22" title="Search for articles in the subject area:'Comparative genomics'"><div class="flagText">Comparative genomics</div></a>
              <div data-categoryid="32937" data-articleid="26270"
                   data-categoryname="Comparative genomics"
                   class="flagImage" title="Flag 'Comparative genomics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Gene+expression%22" title="Search for articles in the subject area:'Gene expression'"><div class="flagText">Gene expression</div></a>
              <div data-categoryid="17515" data-articleid="26270"
                   data-categoryname="Gene expression"
                   class="flagImage" title="Flag 'Gene expression' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Genome+analysis%22" title="Search for articles in the subject area:'Genome analysis'"><div class="flagText">Genome analysis</div></a>
              <div data-categoryid="40539" data-articleid="26270"
                   data-categoryname="Genome analysis"
                   class="flagImage" title="Flag 'Genome analysis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Microarrays%22" title="Search for articles in the subject area:'Microarrays'"><div class="flagText">Microarrays</div></a>
              <div data-categoryid="17255" data-articleid="26270"
                   data-categoryname="Microarrays"
                   class="flagImage" title="Flag 'Microarrays' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Non-small+cell+lung+cancer%22" title="Search for articles in the subject area:'Non-small cell lung cancer'"><div class="flagText">Non-small cell lung cancer</div></a>
              <div data-categoryid="25733" data-articleid="26270"
                   data-categoryname="Non-small cell lung cancer"
                   class="flagImage" title="Flag 'Non-small cell lung cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Survival+analysis%22" title="Search for articles in the subject area:'Survival analysis'"><div class="flagText">Survival analysis</div></a>
              <div data-categoryid="37261" data-articleid="26270"
                   data-categoryname="Survival analysis"
                   class="flagImage" title="Flag 'Survival analysis' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=3262'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=6237'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=3012&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
